{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,6]],"date-time":"2026-06-06T15:07:48Z","timestamp":1780758468248,"version":"3.54.1"},"reference-count":35,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2008,7,12]],"date-time":"2008-07-12T00:00:00Z","timestamp":1215820800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["BMC Neurol"],"published-print":{"date-parts":[[2008,12]]},"DOI":"10.1186\/1471-2377-8-26","type":"journal-article","created":{"date-parts":[[2008,7,15]],"date-time":"2008-07-15T06:13:14Z","timestamp":1216102394000},"source":"Crossref","is-referenced-by-count":23,"title":["Exploratory study of plasma total homocysteine and its relationship to short-term outcome in acute ischaemic stroke in Nigerians"],"prefix":"10.1186","volume":"8","author":[{"given":"Njideka U","family":"Okubadejo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olajumoke O","family":"Oladipo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adekunle A","family":"Adeyomoye","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gbolahan O","family":"Awosanya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mustapha A","family":"Danesi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2008,7,12]]},"reference":[{"key":"188_CR1","volume-title":"Report of the WHO-Wellcome Trust Meeting of Experts, 1-3","author":"World Health Organization","year":"2001","unstructured":"World Health Organization: Secondary prevention of non-communicable diseases in low- and middle-income countries through community-based and health service interventions. Report of the WHO-Wellcome Trust Meeting of Experts, 1-3. 2001, August . Hinxton, Cambridge, UK"},{"issue":"1","key":"188_CR2","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1161\/01.CIR.103.1.163","volume":"103","author":"LB Goldstein","year":"2001","unstructured":"Goldstein LB, Adams R, Becker K, Furberg CD, Gorelick PB, Hademenos G, Hill M, Howard G, Howard VJ, Jacobs B, Levine SR, Mosca L, Sacco RL, Sherman DG, Wolf PA, del Zoppo GJ: Primary Prevention of Ischemic Stroke: a statement for healthcare professionals from the Stroke Council of the American Heart Association. Circulation. 2001, 103 (1): 163-182.","journal-title":"Circulation"},{"issue":"7 suppl 4","key":"188_CR3","first-page":"S15","volume":"53","author":"RL Sacco","year":"1999","unstructured":"Sacco RL, Wolf PA, Gorelick PB: Risk factors and their management for stroke prevention: outlook for 1999 and beyond. Neurology. 1999, 53 (7 suppl 4): S15-S24.","journal-title":"Neurology"},{"key":"188_CR4","doi-asserted-by":"publisher","first-page":"1991","DOI":"10.1161\/01.STR.30.9.1991","volume":"30","author":"PA Wolf","year":"1999","unstructured":"Wolf PA, Clagett GP, Easton JD, Goldstein LB, Gorelick PB, Kelly-Hayes M, Sacco RL, Whisnant JP: Preventing ischemic stroke in patients with prior stroke and transient ischemic attack. A statement for healthcare professionals from the Stroke Council of the American Heart Association. Stroke. 1999, 30: 1991-1994.","journal-title":"Stroke"},{"key":"188_CR5","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1016\/S0140-6736(98)11058-9","volume":"354","author":"GJ Hankey","year":"1999","unstructured":"Hankey GJ, Eikelboom W: Homocysteine and vascular disease. Lancet. 1999, 354: 407-413. 10.1016\/S0140-6736(98)11058-9.","journal-title":"Lancet"},{"key":"188_CR6","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1097\/00019052-200102000-00015","volume":"14","author":"GJ Hankey","year":"2001","unstructured":"Hankey GJ, Eikelboom JW: Homocysteine and stroke. Curr Opin Neurol. 2001, 14: 95-102. 10.1097\/00019052-200102000-00015.","journal-title":"Curr Opin Neurol"},{"key":"188_CR7","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1016\/0021-9150(75)90004-0","volume":"22","author":"KS McCully","year":"1975","unstructured":"McCully KS, Wilson RB: Homocysteine theory of arteriosclerosis. Atherosclerosis. 1975, 22: 215-27. 10.1016\/0021-9150(75)90004-0.","journal-title":"Atherosclerosis"},{"key":"188_CR8","doi-asserted-by":"publisher","first-page":"363","DOI":"10.7326\/0003-4819-131-5-199909070-00008","volume":"131","author":"JW Eikelboom","year":"1999","unstructured":"Eikelboom JW, Lonn E, Genest J, Hankey G, Yusuf S: Homocysteine and cardiovascular disease: a critical review of the epidemiologic evidence. Ann Intern Med. 1999, 131: 363-375.","journal-title":"Ann Intern Med"},{"key":"188_CR9","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1002\/(SICI)1097-4652(200004)183:1<28::AID-JCP4>3.0.CO;2-O","volume":"183","author":"VS Mujumdar","year":"2000","unstructured":"Mujumdar VS, Hayden MR, Tyagi SC: Homocysteine induces calcium second messenger in vascular smooth muscle cells. J Cell Physiol. 2000, 183: 28-33. 10.1002\/(SICI)1097-4652(200004)183:1<28::AID-JCP4>3.0.CO;2-O.","journal-title":"J Cell Physiol"},{"key":"188_CR10","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1016\/S0140-6736(05)78090-9","volume":"351","author":"JC Chambers","year":"1998","unstructured":"Chambers JC, McGregor A, Jean Marie J, Kooner JS: Acute hyperhomocysteinemia and endothelial dysfunction. Lancet. 1998, 351: 36-37. 10.1016\/S0140-6736(05)78090-9.","journal-title":"Lancet"},{"key":"188_CR11","doi-asserted-by":"publisher","first-page":"1119","DOI":"10.1161\/01.CIR.95.5.1119","volume":"85","author":"A Tawakol","year":"1997","unstructured":"Tawakol A, Omland T, Gerhard M, Wu JT, Creager MA: Hyperhomocysteinemia is associated with impaired endothelium-dependent vasodilation in humans. Circulation. 1997, 85: 1119-1121.","journal-title":"Circulation"},{"key":"188_CR12","doi-asserted-by":"publisher","first-page":"632","DOI":"10.1161\/01.STR.0000060203.58958.35","volume":"34","author":"D Tanne","year":"2003","unstructured":"Tanne D, Haim M, Goldbourt U, Boyko V, Doolman R, Adler Y, Brunner D, Behar S, Sela BA: Prospective study of serum homocysteine and risk of ischaemic stroke among patients with preexisting coronary heart disease. Stroke. 2003, 34: 632-636. 10.1161\/01.STR.0000060203.58958.35.","journal-title":"Stroke"},{"key":"188_CR13","doi-asserted-by":"publisher","first-page":"1422","DOI":"10.1001\/archneur.57.10.1422","volume":"57","author":"R Diaz-Arrastia","year":"2000","unstructured":"Diaz-Arrastia R: Homocysteine and neurologic disease. Arch Neurol. 2000, 57: 1422-1427. 10.1001\/archneur.57.10.1422.","journal-title":"Arch Neurol"},{"key":"188_CR14","doi-asserted-by":"publisher","first-page":"1395","DOI":"10.1016\/S0140-6736(95)92407-8","volume":"346","author":"IJ Perry","year":"1995","unstructured":"Perry IJ, Refsum H, Morris RW, Ebrahim SB, Ueland PM, Shaper AG: Prospective study of serum total homocysteine concentration and risk of stroke in middle-aged British men. Lancet. 1995, 346: 1395-1398. 10.1016\/S0140-6736(95)92407-8.","journal-title":"Lancet"},{"key":"188_CR15","doi-asserted-by":"publisher","first-page":"1069","DOI":"10.1161\/01.STR.31.5.1069","volume":"31","author":"JW Eikelboom","year":"2000","unstructured":"Eikelboom JW, Hankey GJ, Anand SS, Lofthouse E, Staples N, Baker RI: Association between high homocysteine and ischemic stroke due to large- and small-artery disease but not other etiologic subtypes of ischemic stroke. Stroke. 2000, 31: 1069-1075.","journal-title":"Stroke"},{"key":"188_CR16","doi-asserted-by":"publisher","first-page":"363","DOI":"10.7326\/0003-4819-131-5-199909070-00008","volume":"131","author":"JW Eikelboom","year":"1999","unstructured":"Eikelboom JW, Lonn E, Genest J, Hankey G, Yusuf S: Homocysteine and cardiovascular disease: a critical review of the epidemiologic evidence. Ann Intern Med. 1999, 131: 363-375.","journal-title":"Ann Intern Med"},{"key":"188_CR17","doi-asserted-by":"publisher","first-page":"1554","DOI":"10.1161\/01.STR.30.8.1554","volume":"30","author":"SJ Kittner","year":"1999","unstructured":"Kittner SJ, Giles WH, Macko RF, Hebel JR, Wozniak MA, Wityk RJ, Stolley PD, Stern BJ, Sloan MA, Sherwin R, Price TR, McCarter RJ, Johnson CJ, Earley CJ, Buchholz DW, Malinow MR: Homocysteine and risk of cerebral infarction in a biracial population: the stroke prevention in young women study. Stroke. 1999, 30: 1554-1560.","journal-title":"Stroke"},{"key":"188_CR18","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1161\/01.CIR.99.1.178","volume":"99","author":"MR Malinow","year":"1999","unstructured":"Malinow MR, Bostom AG, Krauss RM: Homocysteine, diet, and cardiovascular disease. A statement for healthcare professionals from the Nutrition Committee, American Heart Association. Circulation. 1999, 99: 178-182.","journal-title":"Circulation"},{"issue":"2","key":"188_CR19","doi-asserted-by":"crossref","first-page":"127","DOI":"10.55782\/ane-2003-1462","volume":"63","author":"J Pniewski","year":"2003","unstructured":"Pniewski J, Chodakowska-Zebrowska M, Wozniak R, Stepien K, Stafiej A: Plasma homocysteine level and the course of ischaemic stroke. Acta Neurobiol Exp (Wars). 2003, 63 (2): 127-30.","journal-title":"Acta Neurobiol Exp (Wars)"},{"key":"188_CR20","doi-asserted-by":"publisher","first-page":"864","DOI":"10.1161\/01.STR.20.7.864","volume":"20","author":"T Brott","year":"1989","unstructured":"Brott T, Adams HP, Olinger CP, Marler JR, Barsan WG, Biller J, Spilker J, Holleran R, Eberle R, Hertzberg V, Rorick M, Moomaw CJ, Walker M: Measurements of acute cerebral infarction: a clinical examination scale. Stroke. 1989, 20: 864-870.","journal-title":"Stroke"},{"key":"188_CR21","doi-asserted-by":"publisher","first-page":"1565","DOI":"10.1136\/bmj.302.6792.1565","volume":"302","author":"N Poungvarin","year":"1991","unstructured":"Poungvarin N, Viriyavejakul A, Komontri C: Siriraj stroke score and validation study to distinguish supratentorial intracerebral haemorrhage from infarction. BMJ. 1991, 302: 1565-1567.","journal-title":"BMJ"},{"key":"188_CR22","doi-asserted-by":"publisher","first-page":"1581","DOI":"10.1056\/NEJM199512143332401","volume":"333","author":"The National Institutes of Neurological Disorders and Stroke rt-PA Stroke Study Group","year":"1995","unstructured":"The National Institutes of Neurological Disorders and Stroke rt-PA Stroke Study Group: Tissue plasminogen activator for acute ischemic stroke. N Engl J Med. 1995, 333: 1581-1587. 10.1056\/NEJM199512143332401.","journal-title":"N Engl J Med"},{"key":"188_CR23","doi-asserted-by":"publisher","first-page":"573","DOI":"10.1089\/neu.1998.15.573","volume":"15","author":"JTL Wilson","year":"1998","unstructured":"Wilson JTL, Pettigrew LEL, Teasdale GM: Structured interviews for the Glasgow Outcome Scale and the extended Glasgow Outcome Scale. Guidelines for their use. J Neurotrauma. 1998, 15: 573-85.","journal-title":"J Neurotrauma"},{"key":"188_CR24","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1093\/clinchem\/41.7.991","volume":"41","author":"MT Shipchandler","year":"1995","unstructured":"Shipchandler MT, Moore EG: Rapid, fully automated measurement of plasma homocysteine with the Abbott IMx \u00ae analyzer. Clin Chem. 1995, 41: 991-4.","journal-title":"Clin Chem"},{"key":"188_CR25","doi-asserted-by":"publisher","first-page":"795","DOI":"10.1161\/01.STR.26.5.795","volume":"26","author":"A Lindgren","year":"1995","unstructured":"Lindgren A, Brattstrom B, Norrving B, Hultberg B, Andersson A, Johansson BB: Plasma homocysteine in the acute and convalescent phases after stroke. Stroke. 1995, 26: 795-800.","journal-title":"Stroke"},{"key":"188_CR26","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1111\/j.1468-1331.2006.01518.x","volume":"14","author":"E Happaniemi","year":"2007","unstructured":"Happaniemi E, Helenius J, Soinne L, Syrjala M, Kaste M, Tatlisumak T: Serial measurements of plasma homocysteine levels in early and late phases of ischaemic stroke. Eur J Neurol. 2007, 14: 12-17. 10.1111\/j.1468-1331.2006.01518.x.","journal-title":"Eur J Neurol"},{"key":"188_CR27","first-page":"341","volume":"22","author":"RH Glew","year":"2004","unstructured":"Glew RH, Okolie H, Crossey M, Suberu O, Trujillo M, Pereyra M, Vanderjagt DJ: Serum lipid profiles and homocysteine levels in adults with stroke or myocardial infarction in the town of Gombe in northern Nigeria. J Health Popul Nutr. 2004, 22: 341-7.","journal-title":"J Health Popul Nutr"},{"key":"188_CR28","doi-asserted-by":"publisher","first-page":"2263","DOI":"10.1161\/01.STR.0000142374.33919.92","volume":"35","author":"RL Sacco","year":"2004","unstructured":"Sacco RL, Anand K, Lee HS, Boden-Albala B, Stabler S, Allen R, Paik MC: Homocysteine and the risk of ischemic stroke in a triethnic cohort: the NOrthern MAnhattan Study. Stroke. 2004, 35: 2263-9. 10.1161\/01.STR.0000142374.33919.92.","journal-title":"Stroke"},{"key":"188_CR29","first-page":"586","volume":"103","author":"AK Basu","year":"2005","unstructured":"Basu AK, Pal SK, Saha S, Bandyopadhyay R, Mukherjee SC, Sarkar P: Risk factor analysis in ischaemic stroke: a hospital-based study. J Indian Med Assoc. 2005, 103: 586-588.","journal-title":"J Indian Med Assoc"},{"key":"188_CR30","doi-asserted-by":"publisher","first-page":"e13","DOI":"10.1111\/j.1468-1331.2007.01772.x","volume":"14","author":"JD Spence","year":"2007","unstructured":"Spence JD: Plasma total homocysteine in acute stroke. Eur J Neurol. 2007, 14: e13-10.1111\/j.1468-1331.2007.01772.x.","journal-title":"Eur J Neurol"},{"key":"188_CR31","doi-asserted-by":"publisher","first-page":"310","DOI":"10.1007\/s10072-005-0505-7","volume":"26","author":"F Perini","year":"2005","unstructured":"Perini F, Galloni E, Bolgan I, Bader G, Ruffini R, Arzenton E, Alba S, Azzini C, Bartolomei L, Billo G, Bortolon F, Dudine P, Garofalo PG, L'Erario R, Morra M, Parisen P, Stenta G, Toso V: Elevated plasma homocysteine in acute stroke was not associated with severity and outcome: stronger association with small artery disease. Neurol Sci. 2005, 26: 310-8. 10.1007\/s10072-005-0505-7.","journal-title":"Neurol Sci"},{"key":"188_CR32","doi-asserted-by":"publisher","first-page":"15929","DOI":"10.1155\/2007\/15929","volume":"2007","author":"T Yoldas","year":"2007","unstructured":"Yoldas T, Gonen M, Godekmerdan A, Ilhan F, Bayram E: The serum high-sensitive C reactive protein and homocysteine levels to evaluate the prognosis of acute ischaemic stroke. Mediators Inflamm. 2007, 2007: 15929-10.1155\/2007\/15929.","journal-title":"Mediators Inflamm"},{"key":"188_CR33","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1016\/j.apmr.2004.01.031","volume":"86","author":"EH Mizrahi","year":"2005","unstructured":"Mizrahi EH, Fleissig Y, Arad M, Adunsky A: Plasma homocysteine level and functional outcome of patients with ischaemic stroke. Arch Phys Med Rehabil. 2005, 86: 60-3. 10.1016\/j.apmr.2004.01.031.","journal-title":"Arch Phys Med Rehabil"},{"key":"188_CR34","doi-asserted-by":"publisher","first-page":"422","DOI":"10.1001\/archinte.160.4.422","volume":"160","author":"WG Christen","year":"2000","unstructured":"Christen WG, Ajani UA, Glynn RJ, Hennekens CH: Blood levels of homocysteine and increased risks of cardiovascular disease: causal or casual?. Arch Intern Med. 2000, 160: 422-434. 10.1001\/archinte.160.4.422.","journal-title":"Arch Intern Med"},{"key":"188_CR35","first-page":"698","volume":"16","author":"N Takamura","year":"2007","unstructured":"Takamura N, Abe Y, Nakazato M, Maeda T, Wada M, Nakashima K, Kusano Y, Aoyagi K: Determinants of plasma homocysteine levels and carotid intima-media thickness in Japanese. Asia Pac J Clin Nutr. 2007, 16: 698-703.","journal-title":"Asia Pac J Clin Nutr"}],"container-title":["BMC Neurology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-2377-8-26.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/1471-2377-8-26\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-2377-8-26","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,28]],"date-time":"2024-02-28T08:40:43Z","timestamp":1709109643000},"score":1,"resource":{"primary":{"URL":"http:\/\/bmcneurol.biomedcentral.com\/articles\/10.1186\/1471-2377-8-26"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,7,12]]},"references-count":35,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2008,12]]}},"alternative-id":["188"],"URL":"https:\/\/doi.org\/10.1186\/1471-2377-8-26","relation":{},"ISSN":["1471-2377"],"issn-type":[{"value":"1471-2377","type":"electronic"}],"subject":[],"published":{"date-parts":[[2008,7,12]]},"article-number":"26"}}